Page: Viewing Company

Home Icon Home SEC Icon SEC
Create Alert

Viewing Company

Edit Company
Company Name: Hoth Therapeutics, Inc.
CIK: 1711786
Phone: None
Fiscal Year End: None
Entity Type:
SIC: -
Category Type:
Entity Name: None
First Filing Date: 2019-04-01
Last Filing Date: 2025-05-12
SEC Filings
Start End Frame Filed ACCN Value View
2024-01-01 2023-09-30 CY2023Q3I 2024-05-14 0001213900-24-042906 $ 550,500 View
2018-01-01 2018-12-31 CY2018 2019-04-01 0001213900-19-005307 $ 5,031,062 View
2019-01-01 2019-03-31 CY2018Q1 2019-05-15 0001213900-19-008830 $ 7,007,178 View
2019-04-01 2019-06-30 CY2018Q2 2019-08-14 0001213900-19-015804 $ 9,603,134 View
2019-07-01 2019-09-30 CY2018Q3 2019-11-12 0001213900-19-022971 $ 9,886,759 View
2019-01-01 2019-12-31 CY2018 2020-03-02 0001213900-20-005186 $ 9,164,577 View
2020-01-01 2020-03-31 CY2019Q1 2020-05-13 0001213900-20-012014 $ 10,251,068 View
2020-04-01 2020-06-30 CY2019Q2 2020-08-13 0001213900-20-021878 $ 12,304,263 View
2020-07-01 2020-09-30 CY2019Q3 2020-11-10 0001213900-20-036191 $ 13,434,884 View
2020-01-01 2020-12-31 CY2019 2021-03-16 0001213900-21-015764 $ 12,362,833 View
2021-01-01 2021-03-31 CY2021Q1 2021-05-13 0001213900-21-026092 $ 17,677,443 View
2021-04-01 2021-06-30 CY2021Q2 2021-08-11 0001213900-21-041662 $ 23,694,499 View
2021-07-01 2021-09-30 CY2021Q3 2021-11-10 0001213900-21-058131 $ 23,887,839 View
2021-01-01 2021-12-31 CY2020 2022-03-30 0001213900-22-015909 $ -176,974 View
2022-01-01 2022-03-31 CY2021Q1 2022-05-12 0001213900-22-025987 $ 23,974,828 View
2022-04-01 2022-06-30 CY2021Q2 2022-08-12 0001213900-22-047409 $ 31,034,205 View
2022-01-01 2022-06-30 CY2021Q3 2022-11-10 0001213900-22-071279 $ 23,000 View
2022-12-01 2022-12-29 CY2022 2023-03-31 0001213900-23-025455 $ 5 View
2023-01-01 2023-01-03 CY2023Q1 2023-05-15 0001213900-23-039789 $ 0 View
2022-01-01 2023-01-03 CY2022Q2 2023-08-11 0001213900-23-066246 $ 6 View
2023-07-01 2023-09-30 CY2023Q3 2023-11-13 0001213900-23-086133 $ 5,729 View
2023-01-01 2023-12-31 CY2023 2024-03-28 0001213900-24-027213 $ 200,000 View
2024-01-01 2022-12-29 CY2024Q2 2024-08-09 0001213900-24-067131 $ 10,000,000 View
2024-01-01 2023-09-30 CY2023Q3I 2024-11-12 0001213900-24-096778 $ 200,000 View
2023-01-01 2024-12-31 CY2024Q4I 2025-03-28 0001013762-25-004108 $ 4 View
2025-01-01 2025-03-31 CY2025Q1 2025-05-12 0001213900-25-042043 $ 850,500 View
SEC Facts By Type
Type Name Description View
us-gaap Other General and Administrative Expense Amount of general and administrative expense classified as other. View
us-gaap Other Research and Development Expense Amount of other research and development expense. View
us-gaap Payments for Repurchase of Preferred Stock and Preference Stock The cash outflow to reacquire preferred stock during the period. View
dei Entity Common Stock, Shares Outstanding Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. View
dei Entity Public Float The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. View
us-gaap Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Accrued Liabilities, Current Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Deferred Tax Assets, Net of Valuation Allowance, Current Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards classified as current. View
us-gaap Additional Paid in Capital Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. View
us-gaap Share-based Payment Arrangement, Expense Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. View
us-gaap Amortization of Debt Discount (Premium) Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense. View
us-gaap Amortization of Debt Issuance Costs Amount of amortization expense attributable to debt issuance costs. View
us-gaap Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. View
us-gaap Assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Assets, Current Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Cash Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Cash and Cash Equivalents, Period Increase (Decrease) Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes. View
us-gaap Deferred Tax Assets, Operating Loss Carryforwards Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. View
us-gaap Deferred Tax Assets, Operating Loss Carryforwards, Domestic Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards. View
us-gaap Deferred Tax Assets, Tax Credit Carryforwards Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards. View
us-gaap Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation. View
us-gaap Deferred Tax Assets, Valuation Allowance Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. View
us-gaap Depreciation The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. View
us-gaap Cost, Direct Tax and License Amount of tax incurred and cost of license directly related to good produced or service rendered. View
us-gaap Dividend Income, Operating Amount of operating dividend income on securities. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price per share or per unit of warrants or rights outstanding. View
us-gaap Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock. View
us-gaap Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws. View
us-gaap Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. View
us-gaap Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. View
us-gaap Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. View
us-gaap Comprehensive Income (Loss), Net of Tax, Attributable to Parent Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. View
us-gaap Convertible Notes Payable Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder. View
us-gaap Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease) The increase (decrease) in cumulative translation adjustment before transfers included in determining net income. View
us-gaap Deferred Compensation Cash-based Arrangements, Liability, Current Aggregate carrying value as of the balance sheet date of the liabilities for deferred compensation arrangements payable within one year (or the normal operating cycle, if longer). Represents currently earned compensation under cash arrangements (such as a profit-sharing plan, rabbi trust, and employee contract--excluding equity-based arrangements) that is not actually paid until a later date. View
us-gaap Deferred Federal Income Tax Expense (Benefit) Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations. View
us-gaap Deferred Income Tax Expense (Benefit) Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. View
us-gaap Deferred Offering Costs Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period. View
us-gaap Deferred State and Local Income Tax Expense (Benefit) Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations. View
us-gaap Deferred Tax Assets, Net Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting. View
us-gaap Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Percentage of domestic federal statutory tax rate applicable to pretax income (loss). View
us-gaap Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets. View
us-gaap Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates. View
us-gaap Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses. View
us-gaap Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. View
us-gaap Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit). View
us-gaap Effect of Exchange Rate on Cash and Cash Equivalents Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies. View
us-gaap Employee Benefits and Share-based Compensation Amount of expense for employee benefit and equity-based compensation. View
us-gaap Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Amount of cost not yet recognized for nonvested award under share-based payment arrangement. View
us-gaap Employee Stock Ownership Plan (ESOP), Compensation Expense The amount of plan compensation cost recognized during the period. View
us-gaap Equity Method Investment, Ownership Percentage The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. View
us-gaap Equity Method Investments This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. View
us-gaap Escrow Deposit The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy. View
us-gaap Financing Receivable, Change in Present Value, Expense (Reversal) Amount of expense (reversal of expense) for expected credit loss on financing receivable, from change in present value of expected cash flows. View
us-gaap Finite-Lived Patents, Gross Gross carrying amount before accumulated amortization as of the balance sheet date of the costs pertaining to the exclusive legal rights granted to the owner of the patent to exploit an invention or a process for a period of time specified by law. Such costs may have been expended to directly apply and receive patent rights, or to acquire such rights. View
us-gaap Foreign Currency Transaction Gain (Loss), before Tax Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement. View
us-gaap Foreign Currency Transaction Gain (Loss), Unrealized Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement. View
us-gaap Increase (Decrease) in Accounts Payable The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. View
us-gaap Increase (Decrease) in Accrued Liabilities The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. View
us-gaap Increase (Decrease) in Other Accrued Liabilities The increase (decrease) during the reporting period in other expenses incurred but not yet paid. View
us-gaap Interest Expense Amount of the cost of borrowed funds accounted for as interest expense. View
us-gaap Interest Income, Operating Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities. View
us-gaap Operating Leases, Rent Expense Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line. View
us-gaap Liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. View
us-gaap Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. View
us-gaap Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. View
us-gaap Marketable Securities Amount of investment in marketable security. View
us-gaap Marketable Securities, Current Amount of investment in marketable security, classified as current. View
us-gaap Marketable Securities, Realized Gain (Loss) Amount of realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI). View
us-gaap Marketable Securities, Unrealized Gain (Loss) Amount of unrealized gain (loss) on investment in marketable security. View
us-gaap Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. View
us-gaap Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. View
us-gaap Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. View
us-gaap Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. View
us-gaap Nonoperating Income (Expense) The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). View
us-gaap Notes Payable Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer. View
us-gaap Notes Receivable, Related Parties, Current Amounts due from parties associated with the reporting entity as evidenced by a written promise to pay, due within 1 year (or 1 business cycle). View
us-gaap Number of Operating Segments Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues. View
us-gaap Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. View
us-gaap Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues. View
us-gaap Other Additional Capital Amount of additional paid-in capital (APIC) classified as other. View
us-gaap Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. View
us-gaap Other Deferred Costs, Net Net amount of other deferred costs capitalized at the end of the reporting period. Does not include deferred finance costs or deferred acquisition costs of insurance companies. View
us-gaap Other Expenses Amount of expense classified as other. View
us-gaap Other Nonoperating Income Amount of income related to nonoperating activities, classified as other. View
us-gaap Other Nonoperating Income (Expense) Amount of income (expense) related to nonoperating activities, classified as other. View
us-gaap Partners' Capital Account, Public Sale of Units Net of Offering Costs Monetary value of the issuance of new units of limited partnership interest in a public offering, net of offering costs. This is a parenthetical disclosure. View
us-gaap Payments to Acquire Marketable Securities Amount of cash outflow for purchase of marketable security. View
us-gaap Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. View
us-gaap Preferred Stock, Shares Issued Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. View
us-gaap Preferred Stock, Shares Outstanding Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. View
us-gaap Prepaid Expense, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. View
us-gaap Proceeds from Issuance Initial Public Offering The cash inflow associated with the amount received from entity's first offering of stock to the public. View
us-gaap Proceeds from Issuance of Common Limited Partners Units The cash inflow from the issuance of common limited partners units during the period. View
us-gaap Proceeds from Issuance of Common Stock The cash inflow from the additional capital contribution to the entity. View
us-gaap Proceeds from Issuance of Private Placement The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. View
us-gaap Proceeds from Issuance of Warrants The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). View
us-gaap Proceeds from License Fees Received Cash received from licensees for license fees during the current period. View
us-gaap Proceeds from Notes Payable The cash inflow from a borrowing supported by a written promise to pay an obligation. View
us-gaap Proceeds from Other Equity Amount of cash inflow from the issuance of equity classified as other. View
us-gaap Proceeds from Stock Options Exercised Amount of cash inflow from exercise of option under share-based payment arrangement. View
us-gaap Professional Fees A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. View
us-gaap Net Income (Loss), Including Portion Attributable to Noncontrolling Interest The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. View
us-gaap Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. View
us-gaap Realized Investment Gains (Losses) Amount of realized gain (loss) on investment. View
us-gaap Repayments of Notes Payable The cash outflow for a borrowing supported by a written promise to pay an obligation. View
us-gaap Weighted Average Number of Shares Outstanding, Basic and Diluted Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). View
us-gaap Restricted Cash Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. View
us-gaap Restricted Cash and Cash Equivalents Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Restricted Cash Equivalents Amount of cash equivalents restricted as to withdrawal or usage. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Restricted Cash, Noncurrent Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. View
us-gaap Retained Earnings (Accumulated Deficit) The cumulative amount of the reporting entity's undistributed earnings or deficit. View
us-gaap Royalty Expense Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property. View
us-gaap Share-based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate The risk-free interest rate assumption that is used in valuing an option on its own shares. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Gross number of share options (or share units) granted during the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Number of options outstanding, including both vested and non-vested options. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. View
us-gaap Current Foreign Tax Expense (Benefit) Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations. View
us-gaap Current Income Tax Expense (Benefit) Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. View
us-gaap Shares, Issued Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. View
us-gaap Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Impact of Changes in Fair Value of Shares on Amount Increase (decrease) in settlement amount from change in fair value of issuer's equity shares. For example, but not limited to, issuer obligated to pay an additional Y dollars in cash for each $1 decrease in the fair value of one share. View
us-gaap Stockholders' Equity Attributable to Parent Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. View
us-gaap Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity. View
us-gaap Stock Issued During Period, Shares, Issued for Services Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. View
us-gaap Stock Issued During Period, Shares, Other Number of shares of stock issued attributable to transactions classified as other. View
us-gaap Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited. View
us-gaap Stock Issued During Period, Value, Acquisitions Value of stock issued pursuant to acquisitions during the period. View
us-gaap Stock Issued During Period, Value, Conversion of Units Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit). View
us-gaap Stock Issued During Period, Value, New Issues Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. View
us-gaap Stock Issued During Period, Value, Other Value of shares of stock issued attributable to transactions classified as other. View
us-gaap Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited. View
us-gaap Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). View
us-gaap Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). View
us-gaap Stock Issued During Period, Value, Stock Options Exercised Value of stock issued as a result of the exercise of stock options. View
us-gaap Stock Repurchased During Period, Shares Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock. View
us-gaap Stock Repurchased During Period, Value Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock. View
us-gaap Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. View
us-gaap Deferred Federal, State and Local, Tax Expense (Benefit) Amount of deferred state, local, and federal tax expense (benefit) pertaining to income (loss) from continuing operations. View
us-gaap Deferred Tax Assets, Gross Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. View
us-gaap Deferred Tax Assets, in Process Research and Development Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination. View
us-gaap Deferred Tax Assets, Operating Loss Carryforwards, State and Local Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards. View
us-gaap Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals. View
us-gaap Effective Income Tax Rate Reconciliation, Percent Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. View
us-gaap Effective Income Tax Rate Reconciliation, Tax Credit, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits. View
us-gaap Income Taxes Receivable Carrying amount as of the balance sheet date of income taxes previously overpaid to tax authorities (such as U.S. Federal, state and local tax authorities) representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes. Also called income tax refund receivable. View
us-gaap Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible research and development expense. View
us-gaap Interest Income, Securities, Operating, Taxable Amount of operating interest income, including amortization and accretion of premiums and discounts, on securities subject to state, federal and other income tax. View
us-gaap Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures Amount of investment in equity method investee and investment in and advance to affiliate. View
us-gaap Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. View
us-gaap Marketable Securities, Gain (Loss) Amount of unrealized and realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI). View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. View
us-gaap Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. View
us-gaap Accounts Receivable, Allowance for Credit Loss Amount of allowance for credit loss on accounts receivable. View
us-gaap Common Stock, Capital Shares Reserved for Future Issuance Aggregate number of common shares reserved for future issuance. View
us-gaap Costs and Expenses Total costs of sales and operating expenses for the period. View
us-gaap Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap Fair Value, Concentration of Risk, Investment in Federal Home Loan Bank Stock This item represents disclosure of all significant concentrations of credit risk or market risk arising from the subject financial instrument (as defined), whether from an individual counterparty or groups of counterparties. View
us-gaap Fair Value, Net Derivative Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss) Amount of unrealized gain (loss) recognized in income for derivative asset (liability) after deduction of derivative liability (asset), measured at fair value using unobservable input (level 3) and still held. View
us-gaap Income (Loss) from Equity Method Investments Amount of income (loss) for proportionate share of equity method investee's income (loss). View
us-gaap Partners' Capital Account, Units, Sold in Public Offering The number of units sold in a public offering of each class of partners' capital account. Units represent shares of ownership of the general, limited, and preferred partners. View
us-gaap Proceeds from Debt, Net of Issuance Costs The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination. View
us-gaap Proceeds from (Payments for) Trading Securities, Short-term Amount of cash inflow (outflow) from sales and purchases of trading securities. View
us-gaap Proceeds from Warrant Exercises The cash inflow associated with the amount received from holders exercising their stock warrants. View
us-gaap Selling, General and Administrative Expense The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. View
us-gaap Shares Issued, Price Per Share Per share or per unit amount of equity securities issued. View
us-gaap Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. View
us-gaap Investment Interest Rate Rate of interest on investment. View
us-gaap Other Selling, General and Administrative Expense Amount of selling, general and administrative expense classified as other. View
us-gaap Stock Issued The fair value of stock issued in noncash financing activities. View
us-gaap Unrealized Gain (Loss) on Investments Amount of unrealized gain (loss) on investment. View
us-gaap Asset Impairment Charges Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. View
us-gaap Common Unit, Issued Number of common units issued of limited liability company (LLC). View
us-gaap Deferred Other Tax Expense (Benefit) Amount of other deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. For example, but not limited to, acquisition-date income tax benefits or expenses recognized from changes in the acquirer's valuation allowance for its previously existing deferred tax assets resulting from a business combination and adjustments to beginning-of-year balance of a valuation allowance because of a change in circumstance causing a change in judgment about the realizability of the related deferred tax asset in future periods. View
us-gaap Deferred Tax Assets, Other Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other. View
us-gaap Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs Amount of deferred tax liability attributable to taxable temporary differences from research and development costs. View
us-gaap Deposit Liabilities, Accrued Interest Amount of accrued but unpaid interest on deposit liabilities. View
us-gaap Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile. View
us-gaap Fair Value, Option, Changes in Fair Value, Gain (Loss) For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings. View
us-gaap Financing Receivable, Purchased with Credit Deterioration, Amount at Purchase Price Amount at purchase price of financing receivable purchased with credit deterioration. View
us-gaap Insurance Commissions and Fees Income from agency and brokerage operations (includes sales of annuities and supplemental contracts); service charges, commissions, and fees from the sale of insurance and related services; and management fees from separate accounts, deferred annuities, and universal life products. View
us-gaap Interest Income, Other Amount of interest income earned from interest bearing assets classified as other. View
us-gaap Investment Owned, at Fair Value Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities. View
us-gaap Investments, Fair Value Disclosure Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method. View
us-gaap Net Income (Loss) Available to Common Stockholders, Basic Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. View
us-gaap Other Investments Amount of investments classified as other. View
us-gaap Payments to Noncontrolling Interests Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest. View
us-gaap Preferred Stock Dividends and Other Adjustments The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders. View
us-gaap Proceeds from Issuance of Convertible Preferred Stock The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock. View
us-gaap Proceeds from Issuance of Preferred Stock and Preference Stock Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation. View
us-gaap Proceeds from (Repayments of) Notes Payable Amount of cash inflow (outflow) from long-term debt supported by a written promise to pay an obligation. View
us-gaap Purchase Options, Land Carrying amount of an option or options to acquire real property. View
us-gaap Stock Issued During Period, Shares, Purchase of Assets Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination. View
us-gaap Stock Issued During Period, Value, Conversion of Convertible Securities The gross value of stock issued during the period upon the conversion of convertible securities. View
us-gaap Stock Option, Exercise Price, Increase Per share increase in exercise price of option. Excludes change due to standard antidilution provision and option granted under share-based payment arrangement. View
us-gaap Supplemental Deferred Purchase Price A device of credit enhancement where a part of the purchase price for the receivable/ payable is retained to serve as a cash collateral. View
us-gaap Warrant, Exercise Price, Decrease Per share decrease in exercise price of warrant. Excludes change due to standard antidilution provision. View
us-gaap Cash, Uninsured Amount The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation. View
us-gaap Federal Deposit Insurance Corporation Premium Expense Amount of expense for Federal Deposit Insurance Corporation (FDIC) insurance. View
us-gaap Investment Income, Investment Expense Amount of expenses related to the generation of investment income. View
us-gaap Payments for Rent Cash payments to lessor's for use of assets under operating leases. View
us-gaap Proceeds from Bank Debt The cash inflow from bank borrowing during the year. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum The minimum risk-free interest rate assumption that is used in valuing an option on its own shares. View
us-gaap Accounts Payable, Other Amount of obligations incurred and payable classified as other. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Gain (Loss) on Investments Amount of realized and unrealized gain (loss) on investment. View
us-gaap Interest Income, Federal Funds Sold Interest income on federal funds sold. Federal funds sold represent the excess federal funds held by one commercial bank which it lends to another commercial bank, usually at an agreed-upon (federal funds) rate of interest. Such loans generally are of short-duration (overnight). View
us-gaap Marketable Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment Loss Amount of unrealized gain (loss) on investment in marketable security, excluding other-than-temporary impairment (OTTI). View
us-gaap Payments of Stock Issuance Costs The cash outflow for cost incurred directly with the issuance of an equity security. View
us-gaap Proceeds from Sale and Maturity of Marketable Securities The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period. View
us-gaap Share Price Price of a single share of a number of saleable stocks of a company. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. View
us-gaap Share-based Goods and Nonemployee Services Transaction, Tax Benefit The amount of income tax expense reduction and deferred tax asset recorded in the transaction in which equity securities were issued to pay for goods or nonemployee services. View
us-gaap Operating Loss Carryforwards Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. View
us-gaap Debt Instrument, Face Amount Face (par) amount of debt instrument at time of issuance. View
us-gaap Deferred Tax Assets, Capital Loss Carryforwards Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards. View
us-gaap Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from employee benefits, classified as other. View
us-gaap Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Legal Settlements Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the estimated loss from legal settlements. View
us-gaap Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other. View
us-gaap Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement. View
us-gaap Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense. View
us-gaap Federal Income Tax Expense (Benefit), Continuing Operations Amount of current and deferred federal income tax expense (benefit) attributable to income (loss) from continuing operations. View
us-gaap General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. View
us-gaap Effective Income Tax Rate Reconciliation, Tax Credit, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits. View
us-gaap Operating Lease, Liability, Noncurrent Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. View
us-gaap Operating Lease, Right-of-Use Asset Amount of lessee's right to use underlying asset under operating lease. View
us-gaap 1567431 None View
us-gaap Proceeds from Lease Payment, Operating Activity Amount of cash inflow from lease payment, classified as operating activity. View
us-gaap Proceeds from (Payments for) Other Financing Activities Amount of cash inflow (outflow) from financing activities classified as other. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares Number of options vested. View
us-gaap APIC, Share-based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. View
us-gaap Cash, FDIC Insured Amount The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation. View
us-gaap Class of Warrant or Right, Number of Securities Called by Warrants or Rights Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. View
us-gaap Fair Value Adjustment of Warrants Amount of expense (income) related to adjustment to fair value of warrant liability. View
us-gaap Increase (Decrease) in Accounts Payable and Accrued Liabilities The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. View
us-gaap Investment Income, Dividend Amount of dividend income on nonoperating securities. View
us-gaap Operating Lease, Payments Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use. View
us-gaap Sale of Stock, Consideration Received Per Transaction Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate Rate of weighted-average expected volatility for award under share-based payment arrangement. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. View
us-gaap Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Amount of increase in right-of-use asset obtained in exchange for operating lease liability. View
us-gaap Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. View
us-gaap Lessee, Operating Lease, Liability, to be Paid, Year Two Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Lessee, Operating Lease, Liability, Undiscounted Excess Amount Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease. View
us-gaap Operating Lease, Cost Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability. View
us-gaap Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge. View
us-gaap Cash, Cash Equivalents, and Short-term Investments Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable. View
us-gaap Operating Lease, Liability Present value of lessee's discounted obligation for lease payments from operating lease. View
us-gaap Earnings Per Share, Basic and Diluted The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap Increase (Decrease) in Prepaid Expense The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods. View
us-gaap Interest Paid, Excluding Capitalized Interest, Operating Activities Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. View
us-gaap Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. View
us-gaap Payments to Acquire in Process Research and Development The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination. View
us-gaap Payments to Acquire Property, Plant, and Equipment The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. View
us-gaap Preferred Stock, Par or Stated Value Per Share Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. View
us-gaap Research and Development Expense The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. View
us-gaap Deferred Compensation Arrangement with Individual, Allocated Share-based Compensation Expense Amount of expense recognized from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments), awarded to key employees or individuals. Excludes amount related to plans that cover generally all employees (for example, but not limited to, qualified pension plans). View
us-gaap Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments. View
us-gaap Proceeds from Issuance or Sale of Equity The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. View
us-gaap Receivables, Fair Value Disclosure Fair value portion of receivables, including, but not limited to, trade account receivables, note receivables, and loan receivables. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options. View
us-gaap Short-term Debt, Fair Value This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents the amount of short-term debt existing as of the balance sheet date. View
us-gaap Stock Issued During Period, Shares, Employee Stock Ownership Plan Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan. View
us-gaap Unrealized Gain (Loss) on Derivatives The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period. View
us-gaap Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement. View
us-gaap Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure Maximum amount of loss due to credit risk that, based on the gross fair value of the financial instrument, the entity would incur if parties to the financial instruments that make up the concentration failed completely to perform according to the terms of the contracts and the collateral or other security, if any, for the amount due proved to be of no value to the entity. View
us-gaap Temporary Equity, Shares Outstanding The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. View
us-gaap Compensation Expense, Excluding Cost of Good and Service Sold Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Other employee benefit expense includes, but is not limited to, service component of net periodic benefit cost for defined benefit plan. Excludes compensation cost in cost of good and service sold. View
us-gaap Effective Income Tax Rate Reconciliation, Tax Credit, Other, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other tax credits. View
us-gaap Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit. View
us-gaap Investment Income, Interest Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. View
us-gaap Lease, Cost Amount of lease cost recognized by lessee for lease contract. View
us-gaap Lessee, Operating Lease, Liability, to be Paid Amount of lessee's undiscounted obligation for lease payment for operating lease. View
us-gaap Lessee, Operating Lease, Liability, to be Paid, Year One Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Operating Lease, Liability, Current Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares Number of non-vested options outstanding. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price Weighted average grant-date fair value of non-vested options outstanding. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value Weighted average grant-date fair value of options vested. View
us-gaap Short-term Lease, Cost Amount of short-term lease cost, excluding expense for lease with term of one month or less. View
us-gaap Stock Issued, Value, Stock Options Exercised, Net of Tax Benefit (Expense) Value of stock issued as a result of the exercise of stock options, after deduction of related income tax (expense) benefit. View
us-gaap Adjustments to Additional Paid in Capital, Warrant Issued Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants. View
us-gaap Convertible Debt Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company. View
us-gaap Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Amount of cost to be recognized for option under share-based payment arrangement. View
us-gaap Excess Stock, Shares Issued Number of excess stock shares of an entity that have been sold or granted to shareholders. View
us-gaap Investments in Affiliates, Subsidiaries, Associates, and Joint Ventures, Fair Value Disclosure Fair value portion of investments in an entity not consolidated. Includes, but is not limited to, investments in an entity that is affiliated with the reporting entity by means of direct or indirect ownership, an entity in which the reporting entity shares control of the entity with another party or group, an entity which the company has significant influence, but does not have control and subsidiaries that are not required to be consolidated and are accounted for using the equity or cost method. View
us-gaap Liabilities, Fair Value Adjustment Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties. View
us-gaap Liabilities, Noncurrent Amount of obligation due after one year or beyond the normal operating cycle, if longer. View
us-gaap Other Assets, Noncurrent Amount of noncurrent assets classified as other. View
us-gaap Prepaid Rent Amount of asset related to consideration paid in advance for rent that provides economic benefits within a future period of one year or the normal operating cycle, if longer. View
us-gaap Revenues Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). View
us-gaap Stock Issued During Period, Value, Restricted Stock Award, Gross Aggregate value of stock related to Restricted Stock Awards issued during the period. View
us-gaap Warrants and Rights Outstanding Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price. View
us-gaap Assets, Noncurrent Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. View
us-gaap Revenue from Contract with Customer, Including Assessed Tax Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. View
us-gaap Amortization The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. View
us-gaap Gain (Loss) on Termination of Lease Amount of gain (loss) on termination of lease before expiration of lease term. View
us-gaap Other Prepaid Expense, Current Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. View
us-gaap Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices. View
us-gaap Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding. View
us-gaap Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year. View
us-gaap Operating Lease, Right-of-Use Asset, Amortization Expense Amount of amortization expense for right-of-use asset from operating lease. View
us-gaap Prepaid Insurance Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer. View
us-gaap Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices. View
us-gaap Stock Issued During Period, Value, Issued for Services Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. View
Chart of Accounts => Accounts
Name View
Liabilities and Equity View
Liabilities, Current View
Marketable Securities View
Marketable Securities, Current View
Accounts Payable, Current View
Accrued Liabilities, Current View
Additional Paid in Capital View
Share-based Payment Arrangement, Expense View
Amortization of Debt Discount (Premium) View
Amortization of Debt Issuance Costs View
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount View
Assets View
Assets, Current View
Cash View
Cash and Cash Equivalents, at Carrying Value View
Cash and Cash Equivalents, Period Increase (Decrease) View
Cash, Cash Equivalents, and Short-term Investments View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents View
Class of Warrant or Right, Exercise Price of Warrants or Rights View
Common Stock, Par or Stated Value Per Share View
Common Stock, Shares Authorized View
Common Stock, Shares, Issued View
Common Stock, Shares, Outstanding View
Common Stock, Value, Issued View
Comprehensive Income (Loss), Net of Tax, Attributable to Parent View
Convertible Notes Payable View
Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease) View
Deferred Compensation Cash-based Arrangements, Liability, Current View
Deferred Federal Income Tax Expense (Benefit) View
Deferred Income Tax Expense (Benefit) View
Deferred Offering Costs View
Deferred State and Local Income Tax Expense (Benefit) View
Deferred Tax Assets, Net View
Deferred Tax Assets, Net of Valuation Allowance, Current View
Deferred Tax Assets, Operating Loss Carryforwards View
Deferred Tax Assets, Operating Loss Carryforwards, Domestic View
Deferred Tax Assets, Tax Credit Carryforwards View
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost View
Deferred Tax Assets, Valuation Allowance View
Depreciation View
Cost, Direct Tax and License View
Dividend Income, Operating View
Earnings Per Share, Basic and Diluted View
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent View
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent View
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent View
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent View
Effective Income Tax Rate Reconciliation, Other Adjustments, Percent View
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent View
Effect of Exchange Rate on Cash and Cash Equivalents View
Employee Benefits and Share-based Compensation View
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount View
Employee Stock Ownership Plan (ESOP), Compensation Expense View
Equity Method Investment, Ownership Percentage View
Equity Method Investments View
Escrow Deposit View
Financing Receivable, Change in Present Value, Expense (Reversal) View
Finite-Lived Patents, Gross View
Foreign Currency Transaction Gain (Loss), before Tax View
Foreign Currency Transaction Gain (Loss), Unrealized View
Increase (Decrease) in Accounts Payable View
Increase (Decrease) in Accrued Liabilities View
Increase (Decrease) in Other Accrued Liabilities View
Increase (Decrease) in Prepaid Expense View
Interest Expense View
Interest Income, Operating View
Interest Paid, Excluding Capitalized Interest, Operating Activities View
Operating Leases, Rent Expense View
Liabilities View
Marketable Securities, Unrealized Gain (Loss) View
Net Cash Provided by (Used in) Financing Activities View
Net Cash Provided by (Used in) Investing Activities View
Nonoperating Income (Expense) View
Notes Payable View
Notes Receivable, Related Parties, Current View
Number of Operating Segments View
Operating Expenses View
Operating Income (Loss) View
Other Additional Capital View
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax View
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax View
Other Deferred Costs, Net View
Other Expenses View
Other Nonoperating Income View
Other Nonoperating Income (Expense) View
Partners' Capital Account, Public Sale of Units Net of Offering Costs View
Payments to Acquire in Process Research and Development View
Payments to Acquire Marketable Securities View
Preferred Stock, Shares Authorized View
Preferred Stock, Shares Issued View
Preferred Stock, Shares Outstanding View
Prepaid Expense, Current View
Proceeds from Issuance Initial Public Offering View
Proceeds from Issuance of Common Limited Partners Units View
Proceeds from Issuance of Common Stock View
Proceeds from Issuance of Private Placement View
Proceeds from Issuance of Warrants View
Proceeds from License Fees Received View
Proceeds from Notes Payable View
Proceeds from Other Equity View
Proceeds from Stock Options Exercised View
Professional Fees View
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest View
Property, Plant and Equipment, Net View
Realized Investment Gains (Losses) View
Repayments of Notes Payable View
Research and Development Expense View
Restricted Cash View
Restricted Cash and Cash Equivalents View
Restricted Cash Equivalents View
Restricted Cash, Noncurrent View
Retained Earnings (Accumulated Deficit) View
Royalty Expense View
Share-based Payment Arrangement, Noncash Expense View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding View
Shares, Issued View
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Impact of Changes in Fair Value of Shares on Amount View
Stockholders' Equity Attributable to Parent View
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest View
Stock Issued During Period, Shares, Issued for Services View
Stock Issued During Period, Shares, Other View
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures View
Stock Issued During Period, Value, Acquisitions View
Stock Issued During Period, Value, Conversion of Units View
Stock Issued During Period, Value, New Issues View
Stock Issued During Period, Value, Other View
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures View
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture View
Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture View
Stock Issued During Period, Value, Stock Options Exercised View
Stock Repurchased During Period, Shares View
Stock Repurchased During Period, Value View
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount View
Weighted Average Number of Shares Outstanding, Basic and Diluted View
Current Foreign Tax Expense (Benefit) View
Current Income Tax Expense (Benefit) View
Deferred Compensation Arrangement with Individual, Allocated Share-based Compensation Expense View
Deferred Federal, State and Local, Tax Expense (Benefit) View
Deferred Tax Assets, Gross View
Deferred Tax Assets, in Process Research and Development View
Deferred Tax Assets, Operating Loss Carryforwards, State and Local View
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals View
Effective Income Tax Rate Reconciliation, Percent View
Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent View
Effective Income Tax Rate Reconciliation, Tax Credit, Percent View
Income Taxes Receivable View
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount View
Interest Income, Securities, Operating, Taxable View
Earnings Per Share, Basic View
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents View
Marketable Securities, Gain (Loss) View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value View
Weighted Average Number of Shares Outstanding, Basic View
Accounts Receivable, Allowance for Credit Loss View
Common Stock, Capital Shares Reserved for Future Issuance View
Costs and Expenses View
Earnings Per Share, Diluted View
Fair Value, Concentration of Risk, Investment in Federal Home Loan Bank Stock View
Income (Loss) from Equity Method Investments View
Partners' Capital Account, Units, Sold in Public Offering View
Proceeds from Debt, Net of Issuance Costs View
Proceeds from (Payments for) Trading Securities, Short-term View
Proceeds from Warrant Exercises View
Selling, General and Administrative Expense View
Shares Issued, Price Per Share View
Weighted Average Number of Shares Outstanding, Diluted View
Investment Interest Rate View
Other Selling, General and Administrative Expense View
Stock Issued View
Unrealized Gain (Loss) on Investments View
Asset Impairment Charges View
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge View
Common Unit, Issued View
Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure View
Deferred Other Tax Expense (Benefit) View
Deferred Tax Assets, Other View
Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs View
Deposit Liabilities, Accrued Interest View
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent View
Fair Value, Option, Changes in Fair Value, Gain (Loss) View
Financing Receivable, Purchased with Credit Deterioration, Amount at Purchase Price View
Insurance Commissions and Fees View
Interest Income, Other View
Investment Owned, at Fair Value View
Investments, Fair Value Disclosure View
Net Income (Loss) Available to Common Stockholders, Basic View
Other Investments View
Payments to Noncontrolling Interests View
Preferred Stock Dividends and Other Adjustments View
Proceeds from Issuance of Convertible Preferred Stock View
Proceeds from Issuance of Preferred Stock and Preference Stock View
Proceeds from (Repayments of) Notes Payable View
Purchase Options, Land View
Stock Issued During Period, Shares, Purchase of Assets View
Stock Issued During Period, Value, Conversion of Convertible Securities View
Stock Option, Exercise Price, Increase View
Supplemental Deferred Purchase Price View
Temporary Equity, Shares Outstanding View
Warrant, Exercise Price, Decrease View
Cash, Uninsured Amount View
Federal Deposit Insurance Corporation Premium Expense View
Investment Income, Investment Expense View
Payments for Rent View
Proceeds from Bank Debt View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum View
Accounts Payable, Other View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect View
Gain (Loss) on Investments View
Interest Income, Federal Funds Sold View
Marketable Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment Loss View
Payments of Stock Issuance Costs View
Proceeds from Sale and Maturity of Marketable Securities View
Share Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price View
Share-based Goods and Nonemployee Services Transaction, Tax Benefit View
Compensation Expense, Excluding Cost of Good and Service Sold View
Debt Instrument, Face Amount View
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Legal Settlements View
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other View
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent View
Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent View
Federal Income Tax Expense (Benefit), Continuing Operations View
General and Administrative Expense View
Effective Income Tax Rate Reconciliation, Tax Credit, Amount View
Effective Income Tax Rate Reconciliation, Tax Credit, Other, Amount View
Operating Lease, Liability, Noncurrent View
Operating Lease, Right-of-Use Asset View
Operating Loss Carryforwards View
Other General and Administrative Expense View
Other Research and Development Expense View
Payments for Repurchase of Preferred Stock and Preference Stock View
Prepaid Expense and Other Assets, Current View
Proceeds from Lease Payment, Operating Activity View
Proceeds from (Payments for) Other Financing Activities View
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares View
APIC, Share-based Payment Arrangement, Increase for Cost Recognition View
Assets, Noncurrent View
Cash, FDIC Insured Amount View
1553845 View
Class of Warrant or Right, Number of Securities Called by Warrants or Rights View
Fair Value Adjustment of Warrants View
Increase (Decrease) in Accounts Payable and Accrued Liabilities View
Investment Income, Dividend View
Operating Lease, Payments View
Sale of Stock, Consideration Received Per Transaction View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value View
Accumulated Other Comprehensive Income (Loss), Net of Tax View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect View
Marketable Securities, Realized Gain (Loss) View
Net Cash Provided by (Used in) Operating Activities View
Net Income (Loss) Attributable to Parent View
Payments to Acquire Property, Plant, and Equipment View
Preferred Stock, Par or Stated Value Per Share View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price View
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures View
Proceeds from Issuance or Sale of Equity View
Receivables, Fair Value Disclosure View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested View
Short-term Debt, Fair Value View
Stock Issued During Period, Shares, Employee Stock Ownership Plan View
Unrealized Gain (Loss) on Derivatives View
Fair Value, Net Derivative Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss) View
Deferred Tax Assets, Capital Loss Carryforwards View
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits View
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount View
Investment Income, Interest View
Lease, Cost View
Lessee, Operating Lease, Liability, to be Paid View
Lessee, Operating Lease, Liability, to be Paid, Year One View
Lessee, Operating Lease, Liability, to be Paid, Year Two View
Lessee, Operating Lease, Liability, Undiscounted Excess Amount View
Operating Lease, Cost View
Operating Lease, Liability View
Operating Lease, Liability, Current View
Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value View
Short-term Lease, Cost View
Stock Issued, Value, Stock Options Exercised, Net of Tax Benefit (Expense) View
Adjustments to Additional Paid in Capital, Warrant Issued View
Convertible Debt View
Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount View
Excess Stock, Shares Issued View
Investments in Affiliates, Subsidiaries, Associates, and Joint Ventures, Fair Value Disclosure View
Liabilities, Fair Value Adjustment View
Liabilities, Noncurrent View
Other Assets, Noncurrent View
Prepaid Rent View
Revenues View
Stock Issued During Period, Value, Restricted Stock Award, Gross View
Warrants and Rights Outstanding View
Revenue from Contract with Customer, Including Assessed Tax View
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant View
Amortization View
Gain (Loss) on Termination of Lease View
Other Prepaid Expense, Current View
Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding View
Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price View
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year View
Operating Lease, Right-of-Use Asset, Amortization Expense View
Prepaid Insurance View
Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price View
Stock Issued During Period, Value, Issued for Services View